POLG Gene Mitochondrial DNA Depletion Syndrome Type 4A NGS Genetic DNA Test
Introduction
The POLG Gene Mitochondrial DNA Depletion Syndrome Type 4A NGS Genetic DNA Test is an advanced diagnostic test designed to identify mutations in the POLG gene, which can lead to mitochondrial DNA depletion syndrome. This condition is associated with various neurological disorders, making early detection crucial for effective management and treatment.
What the Test Measures
This genetic test utilizes Next Generation Sequencing (NGS) technology to analyze the POLG gene for specific mutations. It detects alterations that may contribute to mitochondrial dysfunction, which can manifest in a range of neurological symptoms.
Who Should Consider This Test?
This test is recommended for individuals experiencing:
- Unexplained neurological symptoms
- Family history of mitochondrial diseases
- Symptoms such as muscle weakness, seizures, or developmental delays
Benefits of Taking the Test
By undergoing the POLG Gene test, patients can:
- Gain clarity on the genetic basis of their symptoms
- Inform treatment decisions and management strategies
- Understand the risk of passing genetic conditions to offspring
- Receive tailored genetic counseling based on results
Understanding Your Results
Results from the POLG Gene test will be interpreted by our genetic specialists. They will provide detailed insights into the findings, including any identified mutations and their implications for health and treatment options.
Test Details and Pricing
Test Name | Discount Price | Regular Price |
---|---|---|
POLG Gene Mitochondrial DNA Depletion Syndrome Type 4A NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
How to Book the Test
To book the POLG Gene Mitochondrial DNA Depletion Syndrome Type 4A NGS Genetic DNA Test, please contact us at +2348110567037 or visit our website. Our team is ready to assist you with the booking process and provide any additional information you may need.
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. The test requires a sample of blood or extracted DNA, or a drop of blood on an FTA card. Prior to testing, a clinical history and a genetic counseling session are recommended to draw a pedigree chart of affected family members.